查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378837

2023-2028 年内分泌检测市场报告（按检测类型、技术、最终用途和地区）

Endocrine Testing Market Report by Test Type, Technology, End Use, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球内分泌检测市场规模达到104亿美元。展望未来， IMARC Group预计到2028年市场规模将达到164亿美元，2022-2028年复合年增长率（CAGR）为7.9%。

内分泌检测是指为测量体内荷尔蒙水平和诊断荷尔蒙相关疾病而进行的医疗程序。此测试有助于检测可能导致某些慢性病发展的荷尔蒙浓度不平衡。这些疾病通常透过细针抽吸 (FNA)、超音波、电脑断层扫描 (CT)、磁振造影 (MRI)、正子发射测试 (PET)、放射性碘扫描 (RAI) 和静脉采样进行测试。由此获得的测试结果可以帮助确定疾病的进展并监测向患者提供的治疗的效果

肾上腺功能不全、库欣氏症、巨人症、甲状腺功能低下症和甲状腺功能亢进等内分泌相关疾病的盛行率日益增加，是推动市场成长的关键因素之一。此外，健康意识的增强以及对及时检测益处的认识的增强也推动了市场的成长。定期检测可以最大限度地降低併发症或病情恶化的风险，尤其是老年患者。与此一致的是，不断增长的老年人口正在成为另一个主要的成长诱导因素。此外，由于冠状病毒（COVID-19）大流行的爆发，内分泌检测被广泛用于检测感染患者的高血糖情况。此外，配备生物感测器的易于操作的创新测试套件的开发，有助于用户友好且经济高效的家庭诊断，正在为市场创造积极的前景。医疗保健中心、实验室和诊断中心还使用技术先进的液相层析和质谱 (LC-MS) 技术来提供高度精确和准确的结果。其他因素，包括医疗保健基础设施的改善，预计将进一步推动市场。

本报告回答的关键问题：

  • 迄今为止，全球内分泌检测市场表现如何，未来几年将如何表现？
  • COVID-19 对全球内分泌检测市场有何影响？
  • 主要区域市场有哪些？
  • 根据测试类型，市场的细分是什么？
  • 基于技术的市场区隔是什么？
  • 根据最终用途分類的市场是怎样的？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球内分泌检测市场的结构如何？谁是主要参与者？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球内分泌检测市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按测试类型分類的市场

  • 甲状腺检查
    • 市场走向
    • 市场预测
  • 胰岛素测试
    • 市场走向
    • 市场预测
  • 人类绒毛膜促性腺激素测试
    • 市场走向
    • 市场预测
  • 催乳素测试
    • 市场走向
    • 市场预测
  • 黄体生成素测试
    • 市场走向
    • 市场预测
  • 黄体酮测试
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：依科技分類的市场

  • 免疫分析
    • 市场走向
    • 市场预测
  • 串联质谱
    • 市场走向
    • 市场预测
  • 感测器技术
    • 市场走向
    • 市场预测
  • 液态联用
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：依最终用途分類的市场区隔

  • 医院
    • 市场走向
    • 市场预测
  • 门诊护理中心
    • 市场走向
    • 市场预测
  • 临床实验室
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • BioMerieux SA
    • DiaSorin SpA
    • F. Hoffmann-La Roche AG (Roche Holding AG)
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Siemens Healthineers AG (Siemens Aktiengesellschaft)
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A2900

Abstract

The global endocrine testing market size reached US$ 10.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.4 Billion by 2028, exhibiting a growth rate (CAGR) of 7.9% during 2022-2028.

Endocrine testing refers to the medical procedures conducted to measure the hormonal levels in the body and the diagnosis of hormone-related disorders. The testing aids in detecting an imbalance in the concentrations of hormones that may lead to the development of certain chronic conditions. These disorders are usually tested by fine-needle aspiration (FNA), ultrasound, computerized tomography (CT), magnetic resonance imaging (MRI), positron emission test (PET), radioactive iodine scan (RAI) and venous sampling. The test results thus obtained can assist in determining the progression of the disorder and monitoring the effects of the treatment being provided to the patient

The increasing prevalence of endocrine-related disorders, such as adrenal insufficiency, Cushing's disease, gigantism, hypothyroidism and hyperthyroidism, represents one of the key factors driving the growth of the market. Furthermore, the increasing health consciousness and awareness regarding the benefits of timely testing is providing a boost to the market growth. Periodic testing minimizes the risks of developing complications or aggravation of the disorder, especially in elderly patients. In line with this, the rising geriatric population is acting as another major growth-inducing factor. Moreover, due to the onset of the coronavirus (COVID-19) pandemic, endocrine testing is being widely used to detect hyperglycemia in infected patients. Additionally, the development of innovative easy-to-operate test kits equipped with biosensors that facilitate user-friendly and cost-effective home-based diagnosis is creating a positive outlook for the market. Healthcare centers, laboratories and diagnostic centers are also using technologically advanced liquid chromatography with mass spectrometry (LC-MS) techniques to provide highly precise and accurate results. Other factors, including improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global endocrine testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on test type, technology and end use.

Breakup by Test Type:

Thyroid Test

Insulin Test

Human Chorionic Gonadotropin Test

Prolactin Test

Luteinizing Hormone Test

Progesterone Test

Others

Breakup by Technology:

Immunoassay

Tandem Mass Spectroscopy

Sensor Technology

LC-MS

Others

Breakup by End Use:

Hospitals

Ambulatory Care Centers

Clinical Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioMerieux SA, DiaSorin S.p.A., F. Hoffmann-La Roche AG (Roche Holding AG), Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG (Siemens Aktiengesellschaft) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global endocrine testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global endocrine testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global endocrine testing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Endocrine Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Thyroid Test
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Insulin Test
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Human Chorionic Gonadotropin Test
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Prolactin Test
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Luteinizing Hormone Test
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Progesterone Test
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Immunoassay
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Tandem Mass Spectroscopy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sensor Technology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 LC-MS
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Care Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinical Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bio-Rad Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 BioMerieux SA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 DiaSorin S.p.A.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche AG (Roche Holding AG)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Laboratory Corporation of America Holdings
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Quest Diagnostics Incorporated
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Siemens Healthineers AG (Siemens Aktiengesellschaft)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Thermo Fisher Scientific Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Endocrine Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Endocrine Testing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Endocrine Testing Market: Breakup by Test Type (in %), 2022
  • Figure 4: Global: Endocrine Testing Market: Breakup by Technology (in %), 2022
  • Figure 5: Global: Endocrine Testing Market: Breakup by End Use (in %), 2022
  • Figure 6: Global: Endocrine Testing Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Endocrine Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Endocrine Testing (Thyroid Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Endocrine Testing (Thyroid Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Endocrine Testing (Insulin Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Endocrine Testing (Insulin Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Endocrine Testing (Human Chorionic Gonadotropin Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Endocrine Testing (Human Chorionic Gonadotropin Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Endocrine Testing (Prolactin Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Endocrine Testing (Prolactin Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Endocrine Testing (Luteinizing Hormone Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Endocrine Testing (Luteinizing Hormone Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Endocrine Testing (Progesterone Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Endocrine Testing (Progesterone Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Endocrine Testing (Other Test Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Endocrine Testing (Other Test Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Endocrine Testing (Immunoassay) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Endocrine Testing (Immunoassay) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Endocrine Testing (Tandem Mass Spectroscopy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Endocrine Testing (Tandem Mass Spectroscopy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Endocrine Testing (Sensor Technology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Endocrine Testing (Sensor Technology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Endocrine Testing (LC-MS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Endocrine Testing (LC-MS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Endocrine Testing (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Endocrine Testing (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Endocrine Testing (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Endocrine Testing (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Endocrine Testing (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Endocrine Testing (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Endocrine Testing (Clinical Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Endocrine Testing (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Endocrine Testing (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Endocrine Testing (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: North America: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: North America: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: United States: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: United States: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Canada: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Canada: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Asia Pacific: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Asia Pacific: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: China: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: China: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Japan: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Japan: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: India: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: India: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: South Korea: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: South Korea: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Australia: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Australia: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Indonesia: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Indonesia: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Europe: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Europe: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Germany: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Germany: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: France: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: France: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: United Kingdom: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: United Kingdom: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Italy: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Italy: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Spain: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Spain: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Russia: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Russia: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Latin America: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Latin America: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Brazil: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Brazil: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Mexico: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Mexico: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Others: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Others: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Middle East and Africa: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Middle East and Africa: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Global: Endocrine Testing Industry: SWOT Analysis
  • Figure 89: Global: Endocrine Testing Industry: Value Chain Analysis
  • Figure 90: Global: Endocrine Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Endocrine Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Endocrine Testing Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 3: Global: Endocrine Testing Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Endocrine Testing Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 5: Global: Endocrine Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Endocrine Testing Market Structure
  • Table 7: Global: Endocrine Testing Market: Key Players